These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23322448)

  • 1. In vitro cytokine release profile: predictive value for metastatic potential in head and neck squamous cell carcinomas.
    Shkeir O; Athanassiou-Papaefthymiou M; Lapadatescu M; Papagerakis P; Czerwinski MJ; Bradford CR; Carey TE; Prince ME; Wolf GT; Papagerakis S
    Head Neck; 2013 Nov; 35(11):1542-50. PubMed ID: 23322448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer.
    Chen Z; Malhotra PS; Thomas GR; Ondrey FG; Duffey DC; Smith CW; Enamorado I; Yeh NT; Kroog GS; Rudy S; McCullagh L; Mousa S; Quezado M; Herscher LL; Van Waes C
    Clin Cancer Res; 1999 Jun; 5(6):1369-79. PubMed ID: 10389921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.
    Dong G; Chen Z; Li ZY; Yeh NT; Bancroft CC; Van Waes C
    Cancer Res; 2001 Aug; 61(15):5911-8. PubMed ID: 11479233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis.
    O-charoenrat P; Rhys-Evans P; Eccles SA
    Cancer; 2001 Aug; 92(3):556-68. PubMed ID: 11505400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study of longitudinal serum cytokine and angiogenesis factor levels as markers of therapeutic response and survival in patients with head and neck squamous cell carcinoma.
    Druzgal CH; Chen Z; Yeh NT; Thomas GR; Ondrey FG; Duffey DC; Vilela RJ; Ende K; McCullagh L; Rudy SF; Muir C; Herscher LL; Morris JC; Albert PS; Van Waes C
    Head Neck; 2005 Sep; 27(9):771-84. PubMed ID: 15920746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-6 antisense-mediated growth inhibition in a head and neck squamous cell carcinoma cell line.
    Bran G; Götte K; Riedel K; Hörmann K; Riedel F
    In Vivo; 2011; 25(4):579-84. PubMed ID: 21708999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression profiles of angiogenic growth factors in squamous cell carcinomas of the head and neck.
    Ninck S; Reisser C; Dyckhoff G; Helmke B; Bauer H; Herold-Mende C
    Int J Cancer; 2003 Aug; 106(1):34-44. PubMed ID: 12794754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tristetraprolin regulates interleukin-6, which is correlated with tumor progression in patients with head and neck squamous cell carcinoma.
    Van Tubergen E; Vander Broek R; Lee J; Wolf G; Carey T; Bradford C; Prince M; Kirkwood KL; D'Silva NJ
    Cancer; 2011 Jun; 117(12):2677-89. PubMed ID: 21656745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum biomarkers in head and neck squamous cell cancer.
    Kaskas NM; Moore-Medlin T; McClure GB; Ekshyyan O; Vanchiere JA; Nathan CA
    JAMA Otolaryngol Head Neck Surg; 2014 Jan; 140(1):5-11. PubMed ID: 24232368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma.
    Riedel F; Zaiss I; Herzog D; Götte K; Naim R; Hörmann K
    Anticancer Res; 2005; 25(4):2761-5. PubMed ID: 16080523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines.
    Bancroft CC; Chen Z; Yeh J; Sunwoo JB; Yeh NT; Jackson S; Jackson C; Van Waes C
    Int J Cancer; 2002 Jun; 99(4):538-48. PubMed ID: 11992543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diet and proinflammatory cytokine levels in head and neck squamous cell carcinoma.
    Arthur AE; Peterson KE; Shen J; Djuric Z; Taylor JM; Hebert JR; Duffy SA; Peterson LA; Bellile EL; Whitfield JR; Chepeha DB; Schipper MJ; Wolf GT; Rozek LS
    Cancer; 2014 Sep; 120(17):2704-12. PubMed ID: 24830761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Head and neck squamous cell carcinoma lymphatic spread and survival: Relevance of vascular endothelial growth factor family for tumor evaluation.
    de Sousa EA; Lourenço SV; de Moraes FP; Vartanian JG; Gonçalves-Filho J; Kowalski LP; Soares FA; Coutinho-Camillo CM
    Head Neck; 2015 Oct; 37(10):1410-6. PubMed ID: 24824527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytokine expression of transforming growth factor-beta2 and interleukin-10 in squamous cell carcinomas of the head and neck. Comparison of tissue expression and serum levels].
    Karcher J; Reisser C; Daniel V; Herold-Mende C
    HNO; 1999 Oct; 47(10):879-84. PubMed ID: 10550371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory mediators drive metastasis and drug resistance in head and neck squamous cell carcinoma.
    St John MA
    Laryngoscope; 2015 Mar; 125 Suppl 3():S1-11. PubMed ID: 25646683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of peripheral blood mononuclear cells to conditioned medium from cultured oral squamous cell carcinomas.
    França CM; Barros FM; Lotufo MA; Fernandes KP; Borra RC
    Braz Oral Res; 2011; 25(5):414-20. PubMed ID: 22031054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incomplete Th2 skewing of cytokines in plasma of patients with squamous cell carcinoma of the head and neck.
    Lathers DM; Achille NJ; Young MR
    Hum Immunol; 2003 Dec; 64(12):1160-6. PubMed ID: 14630398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro evaluation of sialyl Lewis X relationship with head and neck cancer stem cells.
    Czerwinski MJ; Desiderio V; Shkeir O; Papagerakis P; Lapadatescu MC; Owen JH; Athanassiou-Papaefthymiou M; Zheng L; Papaccio G; Prince ME; Papagerakis S
    Otolaryngol Head Neck Surg; 2013 Jul; 149(1):97-104. PubMed ID: 23558285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR antisense treatment of human HNSCC cell lines down-regulates VEGF expression and endothelial cell migration.
    Riedel F; Götte K; Li M; Hörmann K; Grandis JR
    Int J Oncol; 2002 Jul; 21(1):11-6. PubMed ID: 12063543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy +/- chemotherapy.
    De Schutter H; Landuyt W; Verbeken E; Goethals L; Hermans R; Nuyts S
    BMC Cancer; 2005 Apr; 5():42. PubMed ID: 15847702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.